Discovers and develops immunologically based therapeutic anticancer products. Includes progress of clinical trials, and data for investors from company based in Seattle, Washington. (Nasdaq: DNDN)

Visits
357
Added
Nov 25, 2024
Rating
(16)
Rate This Site
QR Code
QR code Download PNG
Embed Badge
Place this code on your website to show you're listed here.